Notably, IL1A expression was increased in MDS patients compared to health controls, while TNFRSF1A, PPID, PLA2G4A, MLKL, TNFSF10, FAS, JAK2, STAT1, STAT3, IRF9, USP21, and BAX expression levels were decreased. This evidence concerns the gene STAT1 and myelodysplastic syndrome.